Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

2

Revenue 2017

Revlimid

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Revlimid was produced by Celgene.

GSK files anti-BCMA drug for myeloma after second trial win

GSK files anti-BCMA drug for myeloma after second trial win Patients in the trial had on average received seven earlier lines of therapy, including an immuno-modulatory drug such as Celgene’s Revlimid (lenalidomide), a proteasome inhibitor such as Takeda’s

J&J’s new Darzalex formulation OK’d for use in Europe

J&J’s new Darzalex formulation OK’d for use in Europe The  new approval means that Darzalex, in combination with Celgene’s Revlimid (lenalidomide) and dexamethasone, (DRd) can be administered for the treatment of newly diagnosed multiple myeloma patients who are ineligible ... 44% compared to treatment

BMS’ Opdivo stalls in Q3, but overall figures still top expectations

BMS’ Opdivo stalls in Q3, but overall figures still top expectations Caforio also pointed to Celgene’s strong results, which were also reported yesterday and revealed a 16% increase in revenues to $4.5bn fuelled by its blood cancer therapies Revlimid (lenalidomide)

European biotech: a new generation of leaders emerges

European biotech: a new generation of leaders emerges The phase 2 L-MIND study in diffuse large B-cell lymphoma (DLBCL) showed the combination of tafasitamab with Celgene’s Revlimid (lenalidomide) had an overall response rate of 60%, with

Celgene boosts IO presence with Immatics deal

Celgene boosts IO presence with Immatics deal Celgene's cash cow blockbuster Revlimid is expected to face limited patent expiry in in the US from 2022, with full exposure not currently scheduled  until 2029, though it will be

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Pegasus

Pegasus inspires healthy decisions through creative, inspirational and integrated communications. Working with ambitious clients, we deliver big ideas and far-reaching...

Latest intelligence

Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...
How will the Tories’ historic win shape the NHS?
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond...
CSR 'Christmas Spirit' 2019
OPEN Health champions CSR over Christmas by giving back to the community and increasing our activities and efforts...

Infographics